This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Company type | Private (family-owned) |
---|---|
Industry | Chemical, pharmaceutical |
Founded | 1927 |
Founder | Elio Bracco |
Headquarters | |
Area served | Worldwide |
Key people | Diana Bracco (President and CEO) |
Products | contrast agents, injectors, medical devices, pharma |
Revenue | €1,300,000,000[1] |
Number of employees | 3400 (2015) |
Website | www |
The Bracco Group is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide,[2] which operates in a variety of business areas.[2]
Bracco has consolidated revenues of more than 1.1 billion euro, of which 75% from international sales.[3] The Group is present in 100 countries and invests approximately 10% of its core diagnostic imaging revenues in research and innovation. In Italy Bracco is also a brand associated with a number of historic pharmaceutical products such as Cebion, Xamamina, Euclorina, the Alfa eye-drops line and the Friliver range of sport supplements.
The Group Chairman and Chief Executive Officer is Diana Bracco. A chemistry graduate from the University of Pavia, Diana Bracco is also Chairman of Expo 2015 Spa, General Section Commissioner for the Italy Pavilion at Expo and Confindustria Vice President for Research & Innovation. Decorated as a Cavaliere del Lavoro, she was President of Assolombarda and, before that, Chairman of Federchimica. In February 2001 she received an Honorary Doctor of Pharmacy degree from University of Pavia. On January 12, 2015, Diana Bracco was "prosecuted on charges of tax evasion and embezzlement, crimes allegedly committed as chairman of the board of the pharmaceutical group Bracco Spa."[4][5][6][7] In October 2016, she was given a two year suspended sentence for tax fraud and embezzlement.[8]
As of 2020, the group has a consolidated turnover of approximately 1.4 billion euros, of which 89% on foreign markets. It is present in 100 countries with 3,587 employees.[9] The Bracco group has 1,800 patents, 7 research and development centers and 9 factories worldwide.[10]